BrainXell

BrainXell is a private, Madison-based biotech firm that has established itself as a leading supplier of specialized human neurons and glia derived from induced pluripotent stem cells (iPSCs). Founded by stem cell neuroscience pioneer Dr. Su-Chun Zhang, the company leverages proprietary differentiation protocols to create highly enriched, disease-relevant cell models for pharmaceutical and biotech partners. It operates primarily as a platform and services company, generating revenue by providing off-the-shelf cell products and custom differentiation services to support drug discovery and translational research. With a client base that includes over 75% of the world's largest pharmaceutical companies, BrainXell is positioned at the intersection of research tools and therapeutic development in neurology.

Proprietary directed differentiation platform for generating high-purity, specialized human neurons and glia from induced pluripotent stem cells (iPSCs).

BrainXell competes in the market for iPSC-derived cells and research models with companies like Fujifilm Cellular Dynamics (CDI), Axol Bioscience, and NeuCyte, as well as larger life science tools providers. Its key competitive advantages are its high-purity specialization, founder's scientific reputation, and established trust with major pharmaceutical companies.